Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus. Swiss Med Wkly [Internet]. 2019 Oct. 27 [cited 2025 Oct. 26];149(4344):w20139. Available from: https://www.smw.ch/index.php/smw/article/view/2687